Perrigo appoints acting head of prescription drug business

Perrigo has announced that Douglas Boothe, executive vice-president and general manager of its prescription pharmaceuticals business, is leaving the company.

John Wesolowski, the firm's senior vice-president of Rx commercial operations, will assume the role of acting general manager for Rx pharmaceuticals while the organisation conducts a search for a permanent successor.

Currently, Mr Wesolowski oversees sales, marketing, contracts and customer service operations within the prescription pharmaceuticals business. In addition to these responsibilities, he will now take charge of of finance and business development functions.

Prior to joining Perrigo as vice-president of commercial operations in February 2004, Mr Wesolowski served in several customer-facing roles at E Fougera and Company from 1993 to 2004.

John Hendrickson, Perrigo's chief executive officer, said: "We are conducting a thorough search process for a business leader who will focus on performance across our Rx portfolio and invest for future long-term growth."

This comes after the firm reached a definitive agreement to sell its US vitamins, minerals and supplements business to International Vitamin Corporation last month. The deal is set to be completed in the next month.